Your browser doesn't support javascript.
loading
Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2.
Du, Ashuai; Zheng, Rong; Disoma, Cyrollah; Li, Shiqin; Chen, Zongpeng; Li, Sijia; Liu, Pinjia; Zhou, Yuzheng; Shen, Yilun; Liu, Sixu; Zhang, Yongxing; Dong, Zijun; Yang, Qinglong; Alsaadawe, Moyed; Razzaq, Aroona; Peng, Yuyang; Chen, Xuan; Hu, Liqiang; Peng, Jian; Zhang, Qianjun; Jiang, Taijiao; Mo, Long; Li, Shanni; Xia, Zanxian.
Afiliación
  • Du A; Department of Cell Biology, School of Life Sciences, Central South University, Changsha 410013, China; Department of Infectious Diseases, Guizhou Provincial People's Hospital, Guizhou 550000, China.
  • Zheng R; Department of Cell Biology, School of Life Sciences, Central South University, Changsha 410013, China.
  • Disoma C; Department of Cell Biology, School of Life Sciences, Central South University, Changsha 410013, China.
  • Li S; Department of Cell Biology, School of Life Sciences, Central South University, Changsha 410013, China.
  • Chen Z; Department of Cell Biology, School of Life Sciences, Central South University, Changsha 410013, China.
  • Li S; Department of Cell Biology, School of Life Sciences, Central South University, Changsha 410013, China.
  • Liu P; Department of Cell Biology, School of Life Sciences, Central South University, Changsha 410013, China.
  • Zhou Y; Department of Cell Biology, School of Life Sciences, Central South University, Changsha 410013, China.
  • Shen Y; Department of Cell Biology, School of Life Sciences, Central South University, Changsha 410013, China.
  • Liu S; Department of Cell Biology, School of Life Sciences, Central South University, Changsha 410013, China.
  • Zhang Y; Department of Cell Biology, School of Life Sciences, Central South University, Changsha 410013, China.
  • Dong Z; Department of Cell Biology, School of Life Sciences, Central South University, Changsha 410013, China.
  • Yang Q; Department of General Surgery, Guizhou Provincial People's Hospital, Guizhou 550000, China.
  • Alsaadawe M; Department of Cell Biology, School of Life Sciences, Central South University, Changsha 410013, China.
  • Razzaq A; Department of Cell Biology, School of Life Sciences, Central South University, Changsha 410013, China.
  • Peng Y; Department of Cell Biology, School of Life Sciences, Central South University, Changsha 410013, China.
  • Chen X; Department of Cell Biology, School of Life Sciences, Central South University, Changsha 410013, China.
  • Hu L; The First Hospital of Changsha, University of South China, Changsha 410201, China.
  • Peng J; Department of General Surgery, Xiangya Hospital, Central South University, Changsha, China.
  • Zhang Q; Institute of Reproductive and Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha 410013, China.
  • Jiang T; Center for Systems Medicine, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Mo L; Department of Cardiology, Xiangya Hospital, Central South University, Changsha 410008, China.
  • Li S; Department of Cell Biology, School of Life Sciences, Central South University, Changsha 410013, China. Electronic address: shannili205121@csu.edu.cn.
  • Xia Z; Department of Cell Biology, School of Life Sciences, Central South University, Changsha 410013, China; Hunan Key Laboratory of Animal Models for Human Diseases, Hunan Key Laboratory of Medical Genetics & Center for Medical Genetics, School of Life Sciences, Central South University, Changsha 410
Int J Biol Macromol ; 176: 1-12, 2021 Apr 15.
Article en En | MEDLINE | ID: mdl-33548314
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Catequina / Proteasas 3C de Coronavirus / SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Int J Biol Macromol Año: 2021 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Catequina / Proteasas 3C de Coronavirus / SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Int J Biol Macromol Año: 2021 Tipo del documento: Article País de afiliación: China